Skip to main content
Premium Trial:

Request an Annual Quote

PreventionGenetics to Use GoldenHelix's VarSeq for Dx Test Offering

NEW YORK (GenomeWeb) – Golden Helix has signed an agreement with PreventionGenetics that allows the latter to implement Golden Helix's VarSeq software into its exome sequencing pipeline.

PreventionGenetics will use the solution to analyze data from an exome sequencing test for clinical diagnostics that the company is preparing to launch in mid-2015. The software streamlines the process of annotating and filtering variants from next-generation sequencing data. It features a simple user interface and scalable architecture with repeatable workflows, tools for note taking and reporting, and filter parameter prototyping.

VarSeq "will allow us to move forward with offering an exome test" by providing tools "to take abundant sequence from exome data and efficiently translate that into molecular diagnoses," Jerry Machado, a clinical molecular geneticist at PreventionGenetics, said in a statement.

Financial and other terms of the agreement were not disclosed.

 

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.